184 related articles for article (PubMed ID: 7993823)
1. Assessment of proliferative activity in Wilms' tumour.
Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME
Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823
[TBL] [Abstract][Full Text] [Related]
2. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
Gulbahar MY; Yuksel H; Guvenc T; Okut H
Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
5. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
[TBL] [Abstract][Full Text] [Related]
6. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
7. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
8. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
9. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
10. Argyrophilic nucleolar organizer regions in Wilms' tumors and related lesions: a histologic and chromosomal correlation.
Mourad WA; Lavallee-Grey M; Pappenhausen P; Essig YP; Rowlands DT
Mod Pathol; 1991 Mar; 4(2):247-52. PubMed ID: 1646458
[TBL] [Abstract][Full Text] [Related]
11. An improved system for quantifying AgNOR and PCNA in canine tumors.
Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
[TBL] [Abstract][Full Text] [Related]
12. Tumor proliferative fraction in infiltrating duct carcinoma.
Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
[TBL] [Abstract][Full Text] [Related]
13. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
[TBL] [Abstract][Full Text] [Related]
14. Tumour cell proliferation rate as determined by MIB-1 antibody in Wilms' tumour.
Juszkiewicz P; Tuziak T; Zbisławski W; Liebhard M; Chosia M
Pol J Pathol; 1997; 48(2):113-9. PubMed ID: 9278108
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of HGF and met in Wilms' tumours.
Alami J; Williams BR; Yeger H
J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
[TBL] [Abstract][Full Text] [Related]
16. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between the prognosis of retinoblastoma and proliferating cell nuclear antigen and argyrophilic protein at nucleolus organizer regions].
Li D; Song X; Gao Y
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):293-6. PubMed ID: 10451965
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar organizer regions in human esophageal disorders: comparison with proliferating cell nuclear antigen by immunostaining.
Miyazaki S; Sasano H; Suzuki T; Sawai T; Nishihira T; Mori S
Mod Pathol; 1992 Jul; 5(4):396-401. PubMed ID: 1353881
[TBL] [Abstract][Full Text] [Related]
20. Expression of proliferating cell nuclear antigen in Wilms' tumor.
Chen F; Liu G; Zhang Z; Li Z; Cai W
Chin Med J (Engl); 1997 May; 110(5):352-3. PubMed ID: 9594301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
